NewsRx

Search our medical news database

Influenza

Model of influenza-host life cycles will help antiviral drug research

Published in Health and Medicine Week, February 20th, 2006

A "starry sky" map linking the myriad interactions between the influenza virus and its human host will help guide researchers in creating new antiviral drugs, say researchers at the University of Texas Southwestern Medical Center.

The online map, part of a project called Reactome, is intended to teach scientists about parts of the influenza life cycle they might not be familiar with, and to help researchers look at specific reactions and figure out ways to block them.

"Understanding how influenza reacts with its host is really critical for the rational design of antiviral drugs and new vaccines," said Richard Scheuermann, professor of pathology at UT...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health and Medicine Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook